UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
Related Articles

News
San Diego Supercomputer Center’s Expanse Provides a Sneak Peek of the Extended Solar Corona
December 3, 2021
sandiegobiotech
News, UCSD News
Comments Off on San Diego Supercomputer Center’s Expanse Provides a Sneak Peek of the Extended Solar Corona
On Saturday, Dec. 4, a total eclipse of the sun will occur at 07:33 (Universal Time) over Antarctica and parts of the South Pacific near the southern tip of Chile. The solar corona – visible to the naked eye onl… […]

News
New Congenital Heart Disease Program Treats Patients with Complex Cardiac Needs
February 11, 2019
sandiegobiotech
News
Comments Off on New Congenital Heart Disease Program Treats Patients with Complex Cardiac Needs

News
Novel Autism Mouse Model Based on an Epigenetic Gene Developed
January 30, 2019
sandiegobiotech
News
Comments Off on Novel Autism Mouse Model Based on an Epigenetic Gene Developed
Translational Psychiatry, researchers at University of California San Diego School of Medicine describe how, in a novel mouse model, epigenetic regulation negatively impacts a downstream gene specifically involve… […]